CLPBY
Price
$8.88
Change
+$0.13 (+1.49%)
Updated
Oct 15 closing price
Capitalization
20.04B
19 days until earnings call
Intraday Buy/Sell Signals
CNVVY
Price
$12.85
Change
-$0.02 (-0.16%)
Updated
Oct 15 closing price
Capitalization
6.34B
28 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CLPBY vs CNVVY

Header iconCLPBY vs CNVVY Comparison
Open Charts CLPBY vs CNVVYBanner chart's image
Coloplast AS
Price$8.88
Change+$0.13 (+1.49%)
Volume$213.08K
Capitalization20.04B
ConvaTec Group
Price$12.85
Change-$0.02 (-0.16%)
Volume$11.42K
Capitalization6.34B
CLPBY vs CNVVY Comparison Chart in %
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPBY vs. CNVVY commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBY is a Hold and CNVVY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (CLPBY: $8.88 vs. CNVVY: $12.85)
Brand notoriety: CLPBY and CNVVY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CLPBY: 77% vs. CNVVY: 49%
Market capitalization -- CLPBY: $19.7B vs. CNVVY: $6.42B
CLPBY [@Pharmaceuticals: Other] is valued at $19.7B. CNVVY’s [@Pharmaceuticals: Other] market capitalization is $6.42B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $156.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBY’s FA Score shows that 1 FA rating(s) are green whileCNVVY’s FA Score has 1 green FA rating(s).

  • CLPBY’s FA Score: 1 green, 4 red.
  • CNVVY’s FA Score: 1 green, 4 red.
According to our system of comparison, CLPBY is a better buy in the long-term than CNVVY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBY’s TA Score shows that 5 TA indicator(s) are bullish while CNVVY’s TA Score has 7 bullish TA indicator(s).

  • CLPBY’s TA Score: 5 bullish, 5 bearish.
  • CNVVY’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, CNVVY is a better buy in the short-term than CLPBY.

Price Growth

CLPBY (@Pharmaceuticals: Other) experienced а -1.00% price change this week, while CNVVY (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.27%. For the same industry, the average monthly price growth was -1.53%, and the average quarterly price growth was +13.93%.

Reported Earning Dates

CLPBY is expected to report earnings on Nov 04, 2025.

CNVVY is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-3.27% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPBY($20B) has a higher market cap than CNVVY($6.34B). CLPBY has higher P/E ratio than CNVVY: CLPBY (32.17) vs CNVVY (30.50). CNVVY YTD gains are higher at: 14.513 vs. CLPBY (-17.585). CLPBY has higher annual earnings (EBITDA): 8.34B vs. CNVVY (567M). CLPBY has more cash in the bank: 726M vs. CNVVY (95.7M). CNVVY has less debt than CLPBY: CNVVY (1.34B) vs CLPBY (24.2B). CLPBY has higher revenues than CNVVY: CLPBY (27.9B) vs CNVVY (2.36B).
CLPBYCNVVYCLPBY / CNVVY
Capitalization20B6.34B316%
EBITDA8.34B567M1,470%
Gain YTD-17.58514.513-121%
P/E Ratio32.1730.50105%
Revenue27.9B2.36B1,184%
Total Cash726M95.7M759%
Total Debt24.2B1.34B1,806%
FUNDAMENTALS RATINGS
CLPBY vs CNVVY: Fundamental Ratings
CLPBY
CNVVY
OUTLOOK RATING
1..100
1217
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
10052
SMR RATING
1..100
3986
PRICE GROWTH RATING
1..100
8457
P/E GROWTH RATING
1..100
7473
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBY's Valuation (14) in the null industry is in the same range as CNVVY (23). This means that CLPBY’s stock grew similarly to CNVVY’s over the last 12 months.

CNVVY's Profit vs Risk Rating (52) in the null industry is somewhat better than the same rating for CLPBY (100). This means that CNVVY’s stock grew somewhat faster than CLPBY’s over the last 12 months.

CLPBY's SMR Rating (39) in the null industry is somewhat better than the same rating for CNVVY (86). This means that CLPBY’s stock grew somewhat faster than CNVVY’s over the last 12 months.

CNVVY's Price Growth Rating (57) in the null industry is in the same range as CLPBY (84). This means that CNVVY’s stock grew similarly to CLPBY’s over the last 12 months.

CNVVY's P/E Growth Rating (73) in the null industry is in the same range as CLPBY (74). This means that CNVVY’s stock grew similarly to CLPBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBYCNVVY
RSI
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
50%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 15 days ago
61%
Bullish Trend 3 days ago
59%
Declines
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 22 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
55%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMCY16.610.27
+1.65%
YieldMax SMCI Option Income Strategy ETF
NETL24.630.27
+1.13%
Fundamental Income Net Lease Rl Estt ETF
MOTI37.870.39
+1.05%
VanEck Morningstar Intl Moat ETF
XLC115.400.81
+0.71%
The Comm Svcs Sel Sect SPDR® ETF
OUSA56.10-0.13
-0.23%
ALPS O'Shares US Quality Div ETF

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with CLPBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then CLPBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
+1.49%
CLPBF - CLPBY
38%
Loosely correlated
N/A
SAUHY - CLPBY
34%
Loosely correlated
+1.75%
SMMNY - CLPBY
33%
Poorly correlated
+1.50%
SONVY - CLPBY
32%
Poorly correlated
+0.80%
ESLOY - CLPBY
32%
Poorly correlated
-0.47%
More

CNVVY and

Correlation & Price change

A.I.dvisor tells us that CNVVY and CRL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNVVY and CRL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
-0.16%
CRL - CNVVY
26%
Poorly correlated
+0.35%
TWST - CNVVY
26%
Poorly correlated
+4.98%
KIDS - CNVVY
24%
Poorly correlated
+0.96%
CLPBY - CNVVY
24%
Poorly correlated
+1.49%
CZMWY - CNVVY
23%
Poorly correlated
-2.05%
More